Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT05189782 · UNKNOWN
Trial details
- NCT number
- NCT05189782
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-10
- Primary completion
- 2023-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.